Mahboob Vaseem 4

What Happened
Mahboob Vaseem, Chief Financial Officer of Kestra Medical Technologies, Ltd. (KMTS), was granted 25,227 restricted stock units (RSUs) on June 3, 2026. The RSUs were granted at a $0 per-share acquisition price (no cash paid) and represent the right to receive one common share per RSU at settlement. This is an award/compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-03; filing date: 2026-06-04 (appears timely).
• Transaction type: Award/Grant (code A); 25,227 RSUs granted at $0.00 per share.
• Vesting: RSUs vest over three years, with one-third vesting on each anniversary of June 3, 2026 (subject to continued service). (Footnote F1)
• Footnote F2: The total includes 5,837 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt under Rule 16a-9.
• Shares owned after transaction: not specified in the provided excerpt.

Context
RSUs are a form of equity compensation that convert to actual shares upon vesting/settlement; they do not involve an immediate cash purchase or sale. Because this was a grant, it signals compensation alignment with the company rather than personal buying or selling of stock. The pro rata distribution noted in F2 is an internal allocation from an entity and is treated as exempt under Rule 16a-9.